Abstract: A computer apparatus (100) includes an OS execution unit (120), an OS-dependent interrupt processing unit (110), and an OS-independent interrupt processing unit (130). When an OS-independent interrupt (201) due to a state of a device (200) occurs, the OS-independent interrupt processing unit (130) determines whether or not to initiate a task (145). When the task (145) is to be initiated, the OS-independent interrupt processing unit (130) turns on the flag (141) and causes the OS execution unit (120) to generate an OS-dependent interrupt (202). When the OS-dependent interrupt (202) is generated, the OS-dependent interrupt processing unit (110) determines whether or not the flag (141) is on, and when the flag (141) is on, initiates the task (145) and turns off the flag (141).

Abstract: A computer apparatus (100) includes an OS execution unit (120), an OS-dependent interrupt processing unit (110), and an OS-independent interrupt processing unit (130). When an OS-independent interrupt (201) due to a state of a device (200) occurs, the OS-independent interrupt processing unit (130) determines whether or not to initiate a task (145). When the task (145) is to be initiated, the OS-independent interrupt processing unit (130) turns on the flag (141) and causes the OS execution unit (120) to generate an OS-dependent interrupt (202). When the OS-dependent interrupt (202) is generated, the OS-dependent interrupt processing unit (110) determines whether or not the flag (141) is on, and when the flag (141) is on, initiates the task (145) and turns off the flag (141).

Abstract: The present invention provides a process of making compounds of formula I, which are useful for the treatment of bacterial infection or disease.

Abstract: The present invention provides a process of making compounds of formula I, which are useful for the treatment of bacterial infection or disease.

Abstract: A first embodiment of the invention relates to novel carbapenem compounds, (1R, 5S, 6S)-2-?1-(1,3-thiazolin-2-yl)azetidin-3-yl!thio-6-?(R)-1-hydroxy-ethyl!-1- methylcarbapen-2-em-3-carboxyic acid derivatives. These carbapenem compounds are represented by the following formula having a beta-coordinated methyl group introduced at the 1-position and a ?1-(1,3-thia-zolin-2-yl)azetidin-3-yl!thio group introduced at the 2-position. ##STR1## In the formula, R is hydrogen; lower alkyl group which is unsubstituted or substituted by hydroxy, lower alkoxy or lower alkoxy-lower alkoxy group; group --COOR.sup.1 (R.sup.1 is hydrogen or lower alkyl group); or group --CONR.sup.2 R.sup.3 (R.sup.2 and R.sup.3 are, independently each other, hydrogen or lower alkyl), and Y is carboxy, --COO.sup..crclbar. or protected carboxy. These compounds are useful antibiotics for prevention and treatment of bacterial infections.

Abstract: Novel carbapenem compounds, (1R,5S,6S)-2-?1-(1,3-thiazolin-2-yl)azetidin-3-yl!thio-6-?(R)-1-hydroxyeth yl!-1-methyl-carbapen-2-em-3-carboxyic acid derivatives.These carbapenem compounds are represented by the following formula having a beta-coordinated methyl group introduced at the 1-position and a ?1-(1,3-thiazolin-2-yl)azetidin-3-yl!thio group introduced at the 2-position. ##STR1## In the formula, R is hydrogen; lower alkyl group which is unsubstituted or substituted by hydroxy, lower alkoxy or lower alkoxy-lower alkoxy group; group --COOR.sup.1 (R.sup.1 is hydrogen or lower alkyl group); or group --CONR.sup.2 R.sup.3 (R.sup.2 and R.sup.3 are, independently each other, hydrogen or lower alkyl), andY is carboxy, --COO.sup..crclbar. or protected carboxy.These compounds are useful antibiotics for prevention and treatment of bacterial infections.

Abstract: This invention relates to 3-mercapto-1-(1,3-thiazolin-2-yl)azetidine represented by the following formula and its acid addition salts ##STR1## and to the production process therefor. The above compounds are useful as intermediates for preparing carbapenem compounds, which have strong antibacterial activity, with convenience and high yield.

Abstract: Novel carbapenem compounds, (1R,5S,6S)-2-[1-(1,3-thiazolin-2-yl)azetidin-3-yl]thio-6-[(R)-1-hydroxyeth yl]-1-methyl-carbapen-2-em-3 -carboxyic acid derivatives.These carbapenem compounds are represented by the following formula having a beta-coordinated methyl group introduced at the 1-position and a [1-(1,3-thiazolin-2-yl)azetidin-3-yl]thio group introduced at the 2-position. ##STR1## In the formula, R is hydrogen; lower alkyl group which is unsubstituted or substituted by hydroxy, lower alkoxy or lower alkoxy-lower alkoxy group; group --COOR.sup.1 (R.sup.1 is hydrogen or lower alkyl group); or group --CONR.sup.2 R.sup.3 (R.sup.2 and R.sup.3 are, independently each other, hydrogen or lower alkyl), andY is carboxy, --COO.sup..crclbar. or protected carboxy.These compounds are useful antibiotics for prevention and treatment of bacterial infections.